All In Biotech

Free tool

FAERS Monitor: Imjudo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761289 or its brand name (Imjudo, Tremelimumab-Actl). Reports on generic versions are filed under their own applications.

Reports

4,428

Serious

4,294

97% of reports

Hospitalization

2,118

Death reported

1,275

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death412
  • diarrhoea301
  • malignant neoplasm progression294
  • pyrexia228
  • colitis194
  • cytokine release syndrome175
  • immune-mediated enterocolitis159
  • rash151
  • liver disorder133
  • pneumonia124
  • pneumonitis103
  • myocarditis100
  • hepatic function abnormal97
  • immune-mediated hepatic disorder97
  • adrenal insufficiency93

Reports by year received

View as table
YearReports
20073
20086
20092
20121
20144
20157
201640
2017409
2018405
201986
2020106
202187
202276
2023516
2024966
2025966
2026748

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,731 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
immune-mediated hepatic disorderSignal97248.6203.122,497
immune-mediated enterocolitisSignal159214.6183.632,147
myocarditisSignal10041.834.43,909
cytokine release syndromeSignal17541.836.16,874
adrenal insufficiencySignal9336.730.03,169
colitisSignal19424.421.34,321
pneumonitisSignal10318.014.91,636
liver disorderSignal13314.312.11,629
malignant neoplasm progressionSignal29413.712.23,448
hepatic function abnormalSignal9712.410.21,002
pyrexiaSignal2283.12.8334
deathSignal4122.32.1305
diarrhoeaSignal3012.22.0206
pneumonia1241.81.546
rash1511.61.438

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.